Stockscreener 앱 받기
8.78
0.23%
-0.02
전일 마감가:
$8.80
열려 있는:
$8.85
하루 거래량:
119.37K
Relative Volume:
0.27
시가총액:
$82.68M
수익:
-
순이익/손실:
$-81.17M
주가수익비율:
-0.8664
EPS:
-10.1344
순현금흐름:
$-82.84M
1주 성능:
-7.58%
1개월 성능:
+6.81%
6개월 성능:
-33.28%
1년 성능:
-76.26%
1일 변동 폭
$8.60
$9.193
1주일 범위
$8.50
$9.49
52주 변동 폭
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
명칭
Korro Bio Inc
전화
617-468-1999
주소
60 FIRST STREET, CAMBRIDGE
KRRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
8.78 | 82.87M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-13 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-16 | 개시 | Chardan Capital Markets | Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-08-14 | 개시 | William Blair | Outperform |
| 2024-03-28 | 재확인 | H.C. Wainwright | Buy |
| 2024-02-27 | 개시 | BMO Capital Markets | Outperform |
| 2023-12-04 | 개시 | H.C. Wainwright | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-10 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-01-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-10-28 | 개시 | Cowen | Outperform |
| 2019-10-28 | 개시 | Goldman | Buy |
| 2019-10-28 | 개시 | JP Morgan | Overweight |
모두보기
Korro Bio Inc 주식(KRRO)의 최신 뉴스
Aug Mood: Is Korro Bio Inc stock a buy or sellPortfolio Gains Report & AI Powered Market Entry Strategies - baoquankhu1.vn
Korro Bio Updates Pipeline, Terminates KRRO-110 REWRITE Trial - TipRanks
Aug Shorts: Is Advantage Solutions Inc backed by strong institutional buyingMarket Sentiment Review & AI Driven Stock Price Forecasts - baoquankhu1.vn
Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Portfolio Shifts: Is Korro Bio Inc. stock positioned for digital transformationTrade Volume Report & Free Long-Term Investment Growth Plans - Bộ Nội Vụ
Korro Bio (NASDAQ:KRRO) Shares Down 5.9% – Here’s What Happened - Defense World
Korro Bio CFO takes medical leave, interim officers appointed - MSN
Will Korro Bio Inc. stock see insider buying2025 Bull vs Bear & Real-Time Price Movement Reports - ulpravda.ru
Inflation Data: Can Korro Bio Inc. stock outperform in 2025 bull marketTrade Analysis Report & Daily Market Momentum Tracking - Улправда
Can Korro Bio Inc. stock outperform in 2025 bull marketWeekly Gains Summary & Long-Term Safe Investment Ideas - Улправда
Market Recap: Can Korro Bio Inc. stock resist market sell offsQuarterly Portfolio Summary & Consistent Profit Alerts - Улправда
Korro Bio (KRRO) price target decreased by 30.77% to 45.90 - MSN
Is Korro Bio Inc. stock gaining market shareQuarterly Profit Report & Free Community Consensus Stock Picks - Улправда
Will Korro Bio Inc. stock keep outperforming rivalsJuly 2025 Rallies & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.
Aug Analyst Calls: Will Korro Bio Inc stock see insider buyingWeekly Market Outlook & Entry and Exit Point Strategies - Bộ Nội Vụ
Korro Bio enhances executive compensation and retention incentives - MSN
User | times-online.comKorro Bio, Inc.Common Stock (Nasdaq:KRRO) Stock Quote - FinancialContent
Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of “Hold” from Analysts - Defense World
Can Korro Bio Stock Hold Up When Markets Turn? - Trefis
Why analysts remain bullish on Korro Bio Inc. stockIPO Watch & Free Low Drawdown Momentum Trade Ideas - Улправда
Can Korro Bio Inc. stock surprise with earnings upsideDividend Hike & Accurate Trade Setup Notifications - Улправда
Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of "Hold" from Analysts - MarketBeat
Published on: 2025-12-20 09:40:01 - Улправда
Loss Report: Why Korro Bio Inc. stock remains resilient2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - Улправда
How institutional buying supports Korro Bio Inc. stock2025 Trading Volume Trends & Trade Opportunity Analysis Reports - Улправда
Why Korro Bio Inc. stock remains resilientJuly 2025 WrapUp & Daily Profit Focused Screening - Улправда
How Korro Bio Inc. stock performs after earningsMarket Performance Recap & Long-Term Safe Investment Plans - Улправда
How Korro Bio Inc. stock reacts to oil prices2025 Trading Volume Trends & Stock Portfolio Risk Management - Улправда
Aug Decliners: Will Korro Bio Inc. stock benefit from sector rotation2025 Stock Rankings & Momentum Based Trading Signals - DonanımHaber
BostInnoMass. showing at CES | Korro's $116M Series B - The Business Journals
Korro Bio amends employment agreement with Jeffrey Cerio, increases compensation - Investing.com Canada
Korro Bio Enhances Executive Compensation and Retention Incentives - TipRanks
Korro Bio (KRRO) boosts Jeffrey Cerio salary, severance and RSU grant - Stock Titan
Can Korro Bio Inc. stock resist market sell offsJuly 2025 Retail & AI Enhanced Execution Alerts - Улправда
Will Korro Bio Inc. stock continue dividend increasesMarket Risk Analysis & Fast Moving Stock Trade Plans - Улправда
Why Korro Bio Inc. stock could be next big winner2025 Top Gainers & Safe Entry Trade Signal Reports - Улправда
Korro Bio’s KRRO-110 Study: A Potential Game-Changer in Genetic Therapy - MSN
Korro Bio (NASDAQ:KRRO) Lowered to Sell Rating by Wall Street Zen - Defense World
Korro Bio downgraded to Hold from Buy at Clear Street - MSN
Stocks of Korro Bio Inc (KRRO) are poised to climb above their peers - setenews.com
Is Korro Bio Inc a good long term investmentCapital Gains Strategies & Small Entry Cost Stocks - earlytimes.in
Will Magenta Lifecare Limited Stock Continue to Outperform in YEARInsider Trading Activity & Market Volatility Strategies - earlytimes.in
Three new option listings and fifteen option delistings on October 21st - MSN
Korro Bio, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Hold” from Analysts - Defense World
Its Stock Has Paid Off Big Time For Korro Bio Inc - Setenews
Korro Bio’s RNA Editing Ambitions Take A Hit After Trial Blowup - Finimize
Korro Bio Inc (KRRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):